Related Experiment Video
Updated: Mar 16, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
TDP-43 pathology and cognition in ALS: A prospective clinicopathologic correlation study
Johannes Prudlo1, Jochem König2, Christina Schuster2
1From the Departments of Neurology (J.P.) and Psychosomatic Medicine (E.K., S.T.) and Institute of Forensic Medicine (A.B.), Rostock University Medical Center; German Center for Neurodegenerative Diseases (DZNE) (J.P., S.T.), Rostock; Institute of Medical Biostatistics, Epidemiology and Informatics (J.K.), University Medical Center, Johannes Gutenberg University Mainz, Germany; Quantitative Neuroimaging Group (C.S.), Academic Unit of Neurology, Biomedical Sciences Institute, Trinity College Dublin, Ireland; Department of Neuropathology (M.N.), University Hospital of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) (M.N.), Tübingen, Germany. johannes.prudlo@med.uni-rostock.de.
Cognitive impairment in amyotrophic lateral sclerosis (ALS) is linked to TDP-43 protein spread in non-motor brain regions. ALS-Frontotemporal Dementia (FTD) shows a distinct TDP-43 pathology pattern compared to ALS without FTD.
Area of Science:
- Neuroscience
- Neuropathology
- Clinical Neurology
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
- TDP-43 proteinopathy is a hallmark of ALS, but its relationship with cognitive decline is not fully understood.
- A systematic spread of TDP-43 pathology throughout the central nervous system (CNS) in ALS has been proposed.
Purpose of the Study:
- To investigate the association between cognitive functioning and the extent and neuroanatomic distribution of TDP-43 pathology in ALS patients.
- To explore clinicopathologic correlations between TDP-43 pathology and cognitive status.
Main Methods:
- Postmortem CNS tissue from 18 ALS patients was analyzed.
- Patients were stratified into three cognitive groups: cognitively not impaired, cognitively impaired, and ALS-frontotemporal dementia (FTD).
- Detailed prospective neuropsychological testing was performed.
Main Results:
- Cognition closely correlates with TDP-43 pathology extent in non-primary motor areas.
- A striking difference in TDP-43 pathology was observed between ALS-FTD and other cognitive groups.
- Absence of Alzheimer pathology and lack of correlation in primary motor regions support the specificity of findings.
Conclusions:
- TDP-43 pathology progression and distribution differ in ALS-FTD compared to ALS without FTD.
- These findings highlight the importance of TDP-43 distribution in understanding cognitive decline in ALS.
More Related Videos
07:00Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
Published on: October 13, 2016
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Parkinson's Disease: Overview
Dementia
The progression of dementia is generally gradual....